Corgard 80mg tablets

देश: यूनाइटेड किंगडम

भाषा: अंग्रेज़ी

स्रोत: MHRA (Medicines & Healthcare Products Regulatory Agency)

सक्रिय संघटक:

Nadolol

थमां उपलब्ध:

Lexon (UK) Ltd

ए.टी.सी कोड:

C07AA12

INN (इंटरनेशनल नाम):

Nadolol

डोज़:

80mg

फार्मास्यूटिकल फॉर्म:

Oral tablet

प्रशासन का मार्ग:

Oral

वर्ग:

No Controlled Drug Status

प्रिस्क्रिप्शन प्रकार:

Valid as a prescribable product

उत्पाद समीक्षा:

BNF: 02040000

सूचना पत्रक

CORGARD 80MG TABLETS
(nadolol)
PATIENT INFORMATION LEAFLET
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE.
*
Keep this leaflet. You may need to read it again
*
If you have any further questions, ask your doctor or pharmacist
*
This medicine has been prescribed for you. Do not pass it on to
others. It
may harm them, even if their symptoms are the same as yours.
*
If any of the side effects get serious, or if you notice any side
effects not
listed in this leaflet, please tell your doctor or pharmacist.
Your medicine is called Corgard 80mg Tablets but will be referred to
as
Corgard Tablets throughout this leaflet.
IN THIS LEAFLET:
What Corgard Tablets are and what they are used for
What you need to know before you take Corgard Tablets
How to take Corgard Tablets
Possible side effects
How to store Corgard Tablets
Content of the pack and other information
WHAT CORGARD TABLETS ARE AND WHAT THEY ARE USED FOR
Corgard Tablets contain a medicine called nadolol.
This belongs to a group of medicines called beta-blockers. It works by
slowing your heart rate or lowering your blood pressure.
Corgard tablets are used for:
*
Chest pain (angina)
*
High blood pressure
*
Uneven or unusually fast heart beats (arrhythmia)
*
Symptoms of an overactive thyroid gland
*
Stopping migraine attacks happening
WHAT YOU NEED TO KNOW BEFORE YOU TAKE CORGARD
TABLETS
DO NOT TAKE CORGARD TABLETS IF:
*
You are allergic (hypersensitive) to nadolol or any of the other
ingredients
of Corgard Tablets (see Section 6: Content of the pack and other
information).
Signs of an allergic reaction include: a rash, swallowing or breathing
problems, swelling of your lips, face, throat or tongue
*
You have or have had asthma, or wheezing
*
You have a very slow heart beat
*
You have heart problems – where you have difficulty breathing and
swollen ankles
Do not take this medicine if any of the above apply to you. If you are
not
sure, talk to your doctor or pharmacist before taking Corgard Tablets.
WARNINGS AND PRECAUTIONS
TAKE SPECIAL CARE

उत्पाद विशेषताएं

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Corgard 80mg Tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_Active Substance: _
Nadolol 80.0mg.
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Tablet.
White or slightly mottled, capsule-shaped, biconvex tablet engraved
“80” on one side
and with a break line on the other side.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Corgard is indicated in the management of:
Angina Pectoris:
For the long-term management of patients with angina
pectoris by continuous medication.
Hypertension:
For the long-term management of essential hypertension,
either alone or in combination with other antihypertensive
agents, especially thiazide-type diuretics.
Arrhythmias:
For the treatment of cardiac tachyarrhythmias.
Migraine:
For the prophylactic management of migraine headache.
The efficacy of Corgard in the treatment of a migraine
attack that has already started has not been established, and
Corgard is not indicated for such use.
Thyrotoxicosis:
For the relief of the symptoms of hyperthyroidism and the
pre-operative preparation of patients for surgery. Nadolol
may be used in conjunction with conventional antithyroid
therapy.
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
Adults:
Dosage should be titrated gradually with at least a week between
increments to assess
response; individuals show considerable variation in their response to
beta-adrenergic
blockade.
Corgard may be given in a once daily dosage without regard to meals.
The dosage
interval should be increased when creatinine clearance is below
50ml/min/1.73m
2
.
If Corgard is to be discontinued, reduce dosage over a period of at
least two weeks
(see warnings).
_Angina pectoris_: Initially 40mg once daily. This may be increased at
weekly intervals
until an adequate response is obtained or excessive bradycardia
occurs. Most patients
respond to 160mg or less daily. The value and safety of daily doses
exceeding 240mg
have not been established.
_Hypertension_: Initially 80mg once